Hopin Illuminates the scene with fifth acquisition of past year

Event tech provider, Hopin, has continued its acquisition drive with the announcement of its acquisition of Attendify, the fifth company it has purchased this past year.  

Since the beginning of 2020, Hopin has acquired StreamYardStreamablejamm, and Boomset, as well as raising more than USD$565m in Series A-C funding. 

Attendify provides tools designed to help event managers deepen audience engagement as well as collect data and surface insights in order to optimise events. With the assistance of Attendify, Hopin will introduce Audience CRM, an attendee data platform that will automatically capture engagement, identify intent signals and use event data to drive growth. 

Johnny Boufarhat, CEO and founder of Hopin, said: “With the addition of Attendify, our event marketing suite gets even better and we can deliver more meaningful tools to organisers that drive growth. And now, access to our platform is even easier, no matter the event budget. With our new free plan, anyone can create events, wherever they are.” 

Michael Balyasny, CEO and founder of Attendify, said: “We are extremely proud to join the Hopin team with the shared goal of creating the best possible user experience in event technology. At Attendify, we’ve always believed not only in the power of events to bring people together to forge meaningful connections but also, in the massive potential that lies in unlocking event data to further enhance the attendee experience.” 

On 7 July, Hopin also announced several company updates as part of Illuminate, a hybrid series bringing together thousands of professionals to highlight innovation in the events industry featuring guest speaker, Malala Yousafzai, Nobel Laureate and co-founder of Malala Fund. 

These updates included the announcement of a free plan, which allows customers to organise an event of up to 100 people and lasting up to two hours. It also announced an integrated GoFundMe into its platform, allowing for donations during the event. 

For more information on Illuminate visit here